CS231964B2 - Manufacturing process of flavanoe derivatives - Google Patents

Manufacturing process of flavanoe derivatives Download PDF

Info

Publication number
CS231964B2
CS231964B2 CS791690A CS169079A CS231964B2 CS 231964 B2 CS231964 B2 CS 231964B2 CS 791690 A CS791690 A CS 791690A CS 169079 A CS169079 A CS 169079A CS 231964 B2 CS231964 B2 CS 231964B2
Authority
CS
Czechoslovakia
Prior art keywords
substituents
groups
substituent
derivatives
formula
Prior art date
Application number
CS791690A
Other languages
Czech (cs)
English (en)
Inventor
John F Batchelor
Denis J Bauer
Harold F Hodson
John W T Selway
David A B Young
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to CS80431A priority Critical patent/CS231969B2/cs
Priority to CS80430A priority patent/CS231968B2/cs
Publication of CS231964B2 publication Critical patent/CS231964B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
CS791690A 1978-03-15 1979-03-14 Manufacturing process of flavanoe derivatives CS231964B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CS80431A CS231969B2 (en) 1978-03-15 1980-01-22 Manufacturing process of flavanoe derivatives
CS80430A CS231968B2 (cs) 1978-03-15 1980-01-22 Způsob výroby flavanových derivátů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1025178 1978-03-15

Publications (1)

Publication Number Publication Date
CS231964B2 true CS231964B2 (en) 1985-01-16

Family

ID=9964425

Family Applications (1)

Application Number Title Priority Date Filing Date
CS791690A CS231964B2 (en) 1978-03-15 1979-03-14 Manufacturing process of flavanoe derivatives

Country Status (32)

Country Link
US (1) US4461907A (fr)
EP (2) EP0004579B1 (fr)
JP (1) JPS54130575A (fr)
AR (2) AR223478A1 (fr)
AT (1) AT366681B (fr)
AU (1) AU529313B2 (fr)
CA (1) CA1193273A (fr)
CS (1) CS231964B2 (fr)
DD (1) DD142340A5 (fr)
DK (1) DK105379A (fr)
EG (1) EG14189A (fr)
ES (3) ES478605A1 (fr)
FI (1) FI790863A (fr)
GR (1) GR67250B (fr)
HU (2) HU187755B (fr)
IL (1) IL56871A (fr)
IN (2) IN150229B (fr)
IT (1) IT1116848B (fr)
MC (1) MC1254A1 (fr)
MY (1) MY8500223A (fr)
NO (3) NO154167C (fr)
NZ (1) NZ189906A (fr)
OA (1) OA06289A (fr)
PH (1) PH18415A (fr)
PL (3) PL122049B1 (fr)
PT (1) PT69349A (fr)
RO (4) RO82173B (fr)
SU (3) SU1072805A3 (fr)
YU (3) YU61679A (fr)
ZA (1) ZA791198B (fr)
ZM (1) ZM2479A1 (fr)
ZW (1) ZW5979A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
US4588733A (en) * 1984-10-19 1986-05-13 Merrell Dow Pharmaceuticals Inc. 2-phenylpyrano[2,3-b]pyridines and their use in inhibiting viruses
US4758679A (en) * 1986-07-18 1988-07-19 Pennwalt Corporation Preparation of 7-(3-(propylamino)-2-hydroxypropoxy)flavone
LU86715A1 (fr) * 1986-12-16 1988-07-14 Oreal Composition cosmetique contenant des derives hydroxyles de chalcone et son utilisation pour la protection de la peau et des cheveux contre les radiations lumineuses,nouveaux derives hydroxyles de chalcone utilises et leur procede de preparation
KR0139296B1 (ko) * 1988-11-21 1998-05-15 가와무라 시게꾸니 칼콘 유도체 및 그 제조 방법
US5063244A (en) * 1990-07-30 1991-11-05 Development Center For Biotechnology Process for the isolation of antifungal agents (5-methoxy-7-hydroxyflavan) from dragon's blood resin and its use in agriculture
US5276058A (en) * 1993-06-09 1994-01-04 Nippon Hypox Laboratories Incorporated 3,4-dihydroxychalcone derivatives
IL118657A0 (en) * 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
US6555523B1 (en) 1999-07-08 2003-04-29 Patrick T. Prendergast Use of cirsiliol and derivatives to treat infections
US6677350B1 (en) 1999-09-22 2004-01-13 Advanced Life Sciences, Inc. Beta-fluoroethyl thiourea compounds and use
JP4742215B2 (ja) * 2003-06-23 2011-08-10 Ｊｎｃ株式会社 クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
ATE342950T1 (de) * 2003-06-23 2006-11-15 Chisso Petrochemical Corp Chromanverbindung, flüssigkristallzusammensetzung enthaltend die verbindung und flüssigkristallanzeigeelement enthaltend die flüssigkristallzusammensetzung
CN109134205B (zh) 2004-05-28 2022-07-19 尤尼根公司 作为双核酶强效抑制剂的二芳基烷烃
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
JP5126942B2 (ja) * 2006-12-26 2013-01-23 静岡県公立大学法人 ５，７−ジデオキシエピガロカテキンガレート、その製法及び抗インフルエンザウイルス剤
WO2014162320A2 (fr) * 2013-04-04 2014-10-09 Sphaera Pharma Pvt. Ltd. Nouveaux analogues d'épicatéchine et polyphénols associés

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518006A1 (de) * 1951-01-28 1969-01-16 Merck Ag E Verfahren zur Herstellung von wasserloeslichen Flavanoidderivaten
FR1221869A (fr) * 1959-01-15 1960-06-07 Coupin Lab Procédé de préparation de dérivés solubles dans l'eau à partir des glucosides flavanoniques
ES265050A1 (es) * 1960-02-23 1961-06-16 Orsymonde Ltd Procedimiento de preparación de derivados insaturados de la trihidroxiacetofenona
CH473114A (de) * 1963-08-28 1969-05-31 Merck Ag E Verfahren zur Herstellung von substituierten Flavanoiden
DE1493976C3 (de) * 1964-01-18 1973-09-13 Merck Patent Gmbh, 6100 Darmstadt Substituierte Flavandenvate sowie Verfahren zu ihrer Herstellung
US3499763A (en) * 1967-05-01 1970-03-10 Ibm Bis phenols as high opacity diazotype couplers
FR1583930A (fr) * 1968-06-27 1969-12-05
GB1283981A (en) * 1969-03-05 1972-08-02 Orsymonde 2,4,6-trihydroxy chalcone derivatives
US3678044A (en) * 1970-10-22 1972-07-18 Chevron Res Substituted flavanones
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions

Also Published As

Publication number Publication date
YU271582A (en) 1983-02-28
RO82526B (ro) 1984-11-30
AR225175A1 (es) 1982-02-26
AU529313B2 (en) 1983-06-02
CA1193273A (fr) 1985-09-10
AU4510879A (en) 1979-09-20
ZM2479A1 (en) 1981-01-21
IN151598B (fr) 1983-06-04
PL122049B1 (en) 1982-06-30
PT69349A (en) 1979-04-01
HU187755B (en) 1986-02-28
JPS54130575A (en) 1979-10-09
RO86258A (fr) 1985-03-15
YU61679A (en) 1983-02-28
HUT35173A (en) 1985-06-28
EP0051061A3 (fr) 1982-06-09
EP0004579B1 (fr) 1982-08-18
ZW5979A1 (en) 1980-10-15
IL56871A (en) 1986-02-28
MC1254A1 (fr) 1980-01-14
EG14189A (en) 1984-09-30
PH18415A (en) 1985-06-24
IL56871A0 (en) 1979-05-31
ZA791198B (en) 1980-11-26
US4461907A (en) 1984-07-24
NZ189906A (en) 1985-07-31
AT366681B (de) 1982-04-26
NO154167C (no) 1986-07-30
ES482787A1 (es) 1980-08-01
YU271482A (en) 1983-02-28
NO840627L (no) 1979-09-18
EP0004579A1 (fr) 1979-10-17
GR67250B (fr) 1981-06-25
EP0051061A2 (fr) 1982-05-05
DD142340A5 (de) 1980-06-18
SU986296A3 (ru) 1982-12-30
DK105379A (da) 1979-09-16
AR223478A1 (es) 1981-08-31
ATA191879A (de) 1981-09-15
RO78419A (fr) 1982-03-24
PL214115A1 (fr) 1980-06-16
NO154167B (no) 1986-04-21
IN150229B (fr) 1982-08-21
RO82173B (ro) 1984-04-30
RO82173A (fr) 1984-04-02
FI790863A (fi) 1979-09-16
ES478605A1 (es) 1980-01-16
OA06289A (fr) 1981-06-30
ES482788A1 (es) 1980-09-01
PL121969B1 (en) 1982-06-30
MY8500223A (en) 1985-12-31
NO840626L (no) 1979-09-18
RO86258B (ro) 1985-03-31
NO790871L (no) 1979-09-18
SU1072805A3 (ru) 1984-02-07
IT7948347A0 (it) 1979-03-14
IT1116848B (it) 1986-02-10
SU991948A3 (ru) 1983-01-23
RO82526A (fr) 1984-10-31

Similar Documents

Publication Publication Date Title
CS231964B2 (en) Manufacturing process of flavanoe derivatives
US10660914B2 (en) Stuffy nose deblocking composition having antiviral activity
KR20020097384A (ko) 기존의 약제에 내성변이를 가지는 바이러스에 유효한 약제
CZ288382B6 (en) Pharmaceutical preparation for treating viral infections
JP7522845B2 (ja) ヌクレオチド系化合物のコロナウイルス感染症の治療での使用
CN105748476A (zh) 亚氨基糖以及治疗丝状病毒性疾病的方法
US6686393B1 (en) Pharmaceutical compositions having antiviral activity against human cytomegalovirus
EP0610444B1 (fr) Utilisation d'un polyhydroxybenzamide ou de l'un de ses dérivés dans la fabrication d'un médicament destiné au traitement d'infections virales
McKinlay et al. Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice
WO2021207271A1 (fr) Mimétiques de glutathion peroxydase de type organosélénium pour le traitement de maladies pulmonaires inflammatoires
Sidwell et al. In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin
WO2021221537A1 (fr) Agent contre le virus sars-cov-2 antiprovir
Peters et al. The experimental chemotherapy of leishmaniasis, V: The activity of potential leishmanicides against ‘L. infantum LV9’in NMRI mice
CN117205319B (zh) Hc030031在制备预防或治疗百草枯中毒引起的肺损伤的药物中的应用
Eaton et al. Further observations of the effect of acridines on the growth of viruses
WO2022143710A1 (fr) Utilisation de pyrroloquinoléine quinone, d'un dérivé et/ou d'un sel de celle-ci en tant que nouveau médicament antiviral et composition pharmaceutique associée
US6140371A (en) Therapeutic uses of known ester and amide compounds
US4617311A (en) Antiasthmatic method
EP4144360A1 (fr) Agent contre le virus sars-cov-2 antiptovir
KR101045985B1 (ko) 아릴 디케토산（ａｄｋ） 유도체를 유효성분으로 포함하는 사스 코로나 바이러스 저해용 조성물
EP1660078A1 (fr) Utilisation d'indomethacine et de ses derives en tant que medicaments antiviraux a large spectre et composition pharmaceutique correspondante
SE451070B (sv) Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom
CN101084892A (zh) 一种抗呼吸道病毒的药物及用途
WO2017202789A1 (fr) Procédés et compositions pharmaceutiques pour le traitement d'infections à filovirus
EP3960173A1 (fr) Inhibiteur d'entérovirus